World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
106
Citations
44498
World Ranking
297
National Ranking
134

Medicine

D-Index
109
Citations
45937
World Ranking
5759
National Ranking
3095

Alicia M. Fry publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Alicia M. Fry sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 383 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Alicia M. Fry D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Alicia M. Fry sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 106 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Alicia M. Fry is affiliated with the Centers for Disease Control and Prevention in the United States. Their research predominantly focuses on infectious diseases and epidemiology, with a substantial emphasis on COVID-19 and related respiratory viral infections.

The scientist has contributed extensively to the field of medicine, authoring 249 publications across various subfields including infectious diseases, epidemiology, modeling and simulation, oncology, and health. Within these subfields, their work is mainly concentrated on infectious diseases and epidemiology.

The main topics of their research include:

  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • COVID-19 epidemiological studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • COVID-19 and healthcare impacts

The scientist has several frequent coauthors in their work, including:

  • Aron J. Hall
  • H. Keipp Talbot
  • Shikha Garg
  • Manjusha Gaglani
  • Lindsay Kim

The publications of Alicia M. Fry span important venues for infectious disease and epidemiology research. The most frequent publication venues include:

  • MMWR Morbidity and Mortality Weekly Report
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases

Selected recent papers authored or coauthored by Alicia M. Fry are:

  • Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020 (2020), published in MMWR Morbidity and Mortality Weekly Report
  • Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020 (2020), published in MMWR Morbidity and Mortality Weekly Report
  • Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021 (2021), published in MMWR Morbidity and Mortality Weekly Report
  • Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 (2020), published in JAMA Internal Medicine
  • Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) (2020), published in Clinical Infectious Diseases

Best Publications

  • Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.

    Shikha Garg;Shikha Garg;Lindsay Kim;Michael Whitaker;Alissa O’Halloran

  • Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

    Seema Jain;Laurie Kamimoto;Anna M Bramley;Ann M. Schmitz

  • Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States

    Alicia M. Siston;Sonja A. Rasmussen;Margaret A. Honein;Alicia M. Fry

  • Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020.

    Sonja J Olsen;Eduardo Azziz-Baumgartner;Alicia P Budd;Lynnette Brammer

  • Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

    Anthony E Fiore;Alicia Fry;David Shay;Larisa Gubareva

  • Transmission of SARS-COV-2 infections in households - Tennessee and Wisconsin, April-September 2020

    Carlos G Grijalva;Melissa A Rolfes;Yuwei Zhu;Huong Q McLean

  • Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.

    Mark G. Thompson;Jefferey L. Burgess;Allison L. Naleway;Harmony L. Tyner

  • Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

    Timothy M Uyeki;Henry H Bernstein;John S Bradley;John S Bradley;Janet A Englund

  • Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States

    Nila J. Dharan;Larisa V. Gubareva;John J. Meyer;Margaret Okomo-Adhiambo

  • Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

    Fiona P. Havers;Carrie Reed;Travis Lim;Joel M. Montgomery

  • Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

    Lindsay Kim;Lindsay Kim;Shikha Garg;Shikha Garg;Alissa O'Halloran;Michael Whitaker;Michael Whitaker

  • Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020.

    Rachel M. Burke;Claire M. Midgley;Alissa Dratch;Martin Fenstersheib

  • Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021.

    Sonja J Olsen;Amber K Winn;Alicia P Budd;Mila M Prill

  • Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.

    Alicia M. Fry;David K. Shay;Robert C. Holman;Aaron T. Curns

  • Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease

    Oliver W Morgan;Anna Bramley;Ashley L. Fowlkes;David S. Freedman

  • Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.

    Lindsay Kim;Michael Whitaker;Alissa O'Halloran;Anita Kambhampati

  • Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

    J. Louie;C. Jean;T. H. Chen;S. Park

  • Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.

    Mark G Thompson;Jefferey L Burgess;Allison L Naleway;Harmony Tyner

  • Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season

    Unknown

  • Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.

    Mark G Thompson;Edward Stenehjem;Shaun Grannis;Sarah W Ball

  • Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009.

    L. M. Napolitano;P. K. Park;K. C. Sihler;T. Papadimos

  • Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection

    Lyn Finelli;Anthony Fiore;Rosaline Dhara;Lynnette Brammer

  • Human Bocavirus: A Novel Parvovirus Epidemiologically Associated with Pneumonia Requiring Hospitalization in Thailand

    Alicia M. Fry;Xiaoyan Lu;Malinee Chittaganpitch;Teresa Peret

Frequent Co-Authors

Brendan Flannery
Brendan Flannery Centers for Disease Control and Prevention
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine
Edward A. Belongia
Edward A. Belongia Marshfield Clinic
Arnold S. Monto
Arnold S. Monto University of Michigan–Ann Arbor
Richard K. Zimmerman
Richard K. Zimmerman University of Pittsburgh
Huong Q. McLean
Huong Q. McLean Marshfield Clinic
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Joseph S. Bresee
Joseph S. Bresee Centers for Disease Control and Prevention
Mary Patricia Nowalk
Mary Patricia Nowalk University of Pittsburgh
Larisa V. Gubareva
Larisa V. Gubareva Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open doors to diverse career pathways in healthcare and research. Many programs are designed to accommodate individuals from varied backgrounds, including those seeking degrees felons can get, helping to build a new professional future.

One emerging field connects microbiology knowledge with patient care: becoming a functional medicine nurse practitioner. This path not only offers a specialized health focus but also appeals for its promising functional medicine nurse salary, which reflects growing demand in holistic healthcare.

Alternatively, combining microbiology with coding skills can lead to roles such as a Certified Professional Coder (CPC). These positions are critical in medical billing and health data management, making the CPC credential a valuable complement to a science background.

Health Information Managers also play a vital role in organizing and protecting patient data, ensuring healthcare systems run smoothly. The field offers competitive opportunities, with a notable health information manager salary reflecting its importance in the industry.

Best Scientists Citing Alicia M. Fry

Trending Scientists

Recently Published Articles